Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wood

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Genes, Chromosomes & Cancer|February 10, 2011
Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphomaMichael R Green, Carlos Aya-Bonilla, Maher K Gandhi, et al.
The Veterinary Record|March 18, 2003
Framework for veterinary education and trainingRoger Blowey, Jason Burgess, Paul Cunliffe, et al.
Tropical Medicine and Health|December 12, 2018
Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveysAlvaro Berg Soto, Zhijing Xu, Peter Wood, et al.
Neuroepidemiology|July 21, 2022
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User DesignMuideen T Olaiya, Nadine E Andrew, Lachlan L Dalli, et al.
Blood|June 11, 2005
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimenElizabeth A Sconce, Tayyaba I Khan, Hilary A Wynne, et al.
Critical Care (London, England)|February 3, 2012
Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI)John-Paul Tung, John F Fraser, Maria Nataatmadja, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2021
Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulationPeter Wood, Giovanni Boyer, Elie Mehanna, et al.
Tropical Medicine and Health|June 21, 2017
Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in VanuatuFasihah Taleo, George Taleo, Patricia M Graves, et al.
Parasites & Vectors|January 23, 2021
Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, MyanmarBenjamin F R Dickson, Patricia M Graves, Ni Ni Aye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up StudyIan W Flinn, Richard van der Jagt, Brad Kahl, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Genes, Chromosomes & Cancer|February 10, 2011
Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphomaMichael R Green, Carlos Aya-Bonilla, Maher K Gandhi, et al.
The Veterinary Record|March 18, 2003
Framework for veterinary education and trainingRoger Blowey, Jason Burgess, Paul Cunliffe, et al.
Tropical Medicine and Health|December 12, 2018
Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveysAlvaro Berg Soto, Zhijing Xu, Peter Wood, et al.
Neuroepidemiology|July 21, 2022
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User DesignMuideen T Olaiya, Nadine E Andrew, Lachlan L Dalli, et al.
Blood|June 11, 2005
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimenElizabeth A Sconce, Tayyaba I Khan, Hilary A Wynne, et al.
Critical Care (London, England)|February 3, 2012
Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI)John-Paul Tung, John F Fraser, Maria Nataatmadja, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2021
Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulationPeter Wood, Giovanni Boyer, Elie Mehanna, et al.
Tropical Medicine and Health|June 21, 2017
Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in VanuatuFasihah Taleo, George Taleo, Patricia M Graves, et al.
Parasites & Vectors|January 23, 2021
Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, MyanmarBenjamin F R Dickson, Patricia M Graves, Ni Ni Aye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up StudyIan W Flinn, Richard van der Jagt, Brad Kahl, et al.
Pageof 6